Join Clinical Trials
  • Login
  • Home
  • Clinical Trial Categories
  • Youths - Birth - 17
  • Florida


Menu

Choose Which Database to Search - Volunteer Database - Clinical Trial Database Create an Account - VOLUNTEER Accounts - RECRUITER Accounts Account Login - Volunteers Login - Recruiters Login Join a Clinical Trial Clinical Trials by Category Clinical Trials by Location Submit a Clinical Trial Frequently Asked Questions Contact Us Sitemap Blog

Categories

    Healthy Volunteers Adults - 18 - 64 Youths - Birth - 17 Seniors - 65 + Expanded Access Compensated Trials Clinical Trials by Condition Trials by Drug Type Trials for Rare Conditions

Recent Listings

  • Post your clinical trial on JoinClinicalTrials.com

    Ellijay, Georgia 30536
    United States

    Post your clinical trial on JoinClinicalTrials.com

    05-09-2019 01:01PM

JoinClinicalTrials.com

Alachua

Jacksonville

Miami

Tampa

Saint Petersburg

Hialeah

Orlando

Fort Lauderdale

Tallahassee

Hollywood

Pembroke Pines

Coral Springs

Clearwater

Cape Coral

Gainesville

Port Saint Lucie

Miami Beach

Sunrise

Plantation

West Palm Beach

Palm Bay

Pensacola

Panama City


Results

Post your clinical trial on JoinClinicalTrials.com
Hot

Post your clinical trial on JoinClinicalTrials.com


Ellijay, Georgia 30536
United States

Post your clinical trial on JoinClinicalTrials.com to reach thousands of viewer daily. Our Clinical Trial Listings have consistently proven to be an ...

Results 1 - 1 of 1
  • <<
  • <
  • 1
  • >
  • >>

  • Evaluation of Pain Alleviating Strategies During Allergy Shots
    NCT04181632
    Conditions:   Immunotherapy;   Allergy
    Interventions:   Device: Buzzy Bee with Ice pack;   Device: Buzzy Bee without Ice pack;   Device: Shot Blocker
    Sponsor:   Nemours Children's Clinic
    Recruiting
  • Remote Microphone (RM) - A Comparative Study
    NCT04147611
    Condition:   Hearing Loss, Conductive
    Interventions:   Device: BAHA;   Device: Wireless Audio Streaming Accessory;   Device: Digital Adaptive RM System
    Sponsors:   University of Miami;   Cochlear
    Recruiting
  • Rescue of Infants With Mct8 Deficiency
    NCT04143295
    Condition:   Mct8 (Slc16A2)-Specific Thyroid Hormone Cell Transporter Deficiency
    Intervention:   Drug: Diiodothyropropionic acid
    Sponsor:   Roy E. Weiss, M.D.
    Available
  • Routine Versus no Assessment of Gastric Residual Volumes in Preterm Infants
    NCT04062851
    Conditions:   Gastric Residual Volume;   Preterm Infant;   Feeding Disorder Neonatal
    Intervention:   Other: No Gastric residual volume monitoring
    Sponsor:   Florida Hospital
    Recruiting
  • Evaluation of the Spark of Duval Intervention
    NCT04044027
    Condition:   Teen Pregnancy Prevention
    Intervention:   Behavioral: S.P.A.R.K (Speaking to the Potential, Ability and Resilience inside Kids) Teen Pregnancy Prevention and Mentoring
    Sponsor:   University of South Florida
    Recruiting
  • Addition of Acetaminophen in Standard PDA Management
    NCT04026464
    Condition:   Patent Ductus Arteriosus
    Interventions:   Drug: Intravenous Ibuprofen;   Drug: Intravenous Ibuprofen + Oral Acetaminophen
    Sponsor:   University of Florida
    Not yet recruiting
  • Skeletal Muscle Effects of GH in Boys
    NCT04020913
    Conditions:   Growth Hormone Deficiency;   Idiopathic Short Stature
    Intervention:   Drug: Somatropin injection
    Sponsors:   Nemours Children's Clinic;   Novo Nordisk A/S
    Recruiting
  • MCRF Clinical Pilot Study
    NCT03991585
    Condition:   Emotional Adjustment
    Intervention:   Behavioral: Musical Contour Regulation Facilitation (MCRF)
    Sponsors:   University of Miami;   American Music Therapy Association;   University of Kansas
    Active, not recruiting
  • Reducing Obesity Health Disparities in Hispanic Youth
    NCT03943628
    Conditions:   Overweight;   Family Relations;   Adolescent Behavior;   Drug Use;   Sexual Behavior
    Intervention:   Behavioral: Familias Unidas
    Sponsors:   University of Miami;   National Institutes of Health (NIH);   National Institute on Minority Health and Health Disparities (NIMHD)
    Completed
  • The FOUNDATION Study
    NCT03939546
    Condition:   Preterm Infant
    Intervention:   Other: B. infantis EVC001
    Sponsor:   Evolve BioSystems, Inc.
    Recruiting
  • Ideal Steroids for Asthma Treatment in the PICU
    NCT03900624
    Condition:   Asthma Childhood
    Intervention:   Drug: Dexamethasone
    Sponsor:   Johns Hopkins All Children's Hospital
    Enrolling by invitation
  • Culturally Modified Family Based Therapy for Haitian Youth in South Florida
    NCT03876171
    Condition:   Problem Behavior
    Interventions:   Behavioral: Haitian youth and family intervention study: family functioning;   Behavioral: Haitian youth intervention study: youth psychoeducational;   Behavioral: Haitian family intervention study: family psychoeducational;   Behavioral: Diversion Programs
    Sponsors:   University of Miami;   National Institute on Drug Abuse (NIDA)
    Recruiting
  • Targeting Burdensomeness Among Clinic Referred Youth
    NCT03781037
    Condition:   Perceived Burdensomeness Toward Others
    Intervention:   Behavioral: GIVE Module
    Sponsor:   Florida International University
    Recruiting
  • Arterial Oxygen Saturation on Ventilatory Stability in Extremely Premature Infants
    NCT03695900
    Conditions:   Apnea of Prematurity;   Desaturation of Blood;   Central Apnea;   Periodic Breathing;   Obstructive Apnea of Newborn
    Interventions:   Other: Targeting SpO2 at 93-95%;   Other: Targeting SpO2 at 90-92%
    Sponsors:   University of Miami;   The Gerber Foundation
    Recruiting
  • Evaluation of Trigeminal Nerve Blockade
    NCT03632044
    Conditions:   Mouth Abnormalities;   Cleft Palate;   Birth Defect
    Interventions:   Drug: Ropivacaine;   Other: Sham Comparator
    Sponsor:   University of Florida
    Enrolling by invitation
  • Pharmacokinetic Study of DYANAVEL XR (Amphetamine) Extended-release Oral Suspension, in Children Aged 4 to 5 Years
    NCT03610464
    Condition:   Attention Deficit Hyperactivity Disorder
    Intervention:   Drug: Amphetamine Extended Release Suspension [Dyanavel]
    Sponsor:   Tris Pharma, Inc.
    Completed
  • Inhaled Nitric Oxide for Pulmonary Hypertension and Bronchopulmonary Dysplasia
    NCT03576885
    Conditions:   Pulmonary Hypertension;   Bronchopulmonary Dysplasia
    Interventions:   Drug: inhaled nitric oxide;   Drug: Placebo
    Sponsors:   Florida Hospital;   Mallinckrodt;   Thrasher Research Fund
    Recruiting
  • Improving Satisfaction, Engagement and Outcomes Among Traditionally Underserved Children Through Cultural Formulation
    NCT03499600
    Condition:   Disruptive Behavior
    Interventions:   Behavioral: Clinical Assessment and CFI;   Behavioral: Clinical Assessment
    Sponsors:   Florida International University;   University of Miami
    Completed
  • PEARLS Intervention
    NCT03260062
    Condition:   Deafness, Bilateral
    Interventions:   Behavioral: Parent-Child Early Approaches to Raising Language Skills;   Other: Standard Care Speech therapy
    Sponsors:   University of Miami;   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting
  • Technology and Early Anxiety Treatment
    NCT03255122
    Condition:   Anxiety Disorders
    Interventions:   Behavioral: I-CALM;   Behavioral: Delayed I-CALM
    Sponsors:   Florida International University;   Andrew Kukes Foundation for Social Anxiety
    Recruiting
  • Intranasal Oxytocin for Infants With Prader-Willi Syndrome
    NCT03245762
    Condition:   Prader-Willi Syndrome
    Interventions:   Drug: Oxytocin;   Drug: Placebo
    Sponsors:   University of Florida;   Prader-Willi Syndrome Association
    Completed
  • Comparison of Primary Extubation Failure Between NIPPV and NI-NAVA
    NCT03242057
    Conditions:   Preterm Infant;   BPD - Bronchopulmonary Dysplasia;   Barotrauma
    Interventions:   Other: NAVA;   Other: NIPPV
    Sponsor:   University of Florida
    Completed
  • A Crowdsourced Social Media Portal for Parents of Very Young Children With Type 1 Diabetes
    NCT03222180
    Condition:   Type 1 Diabetes Mellitus
    Intervention:   Behavioral: Website
    Sponsor:   Nemours Children's Clinic
    Active, not recruiting
  • Methadone Demonstration Project
    NCT03134703
    Condition:   Neonatal Abstinence Syndrome
    Interventions:   Drug: Methadone;   Drug: Morphine
    Sponsors:   Johns Hopkins All Children's Hospital;   Florida Department of Health
    Terminated
  • Efficacy of Auricular Acupuncture on Neonatal Abstinence Syndrome
    NCT02872077
    Condition:   Neonatal Abstinence Syndrome
    Intervention:   Other: Auricular acupuncture
    Sponsor:   University of South Florida
    Completed
  • Antibiotic "Dysbiosis" in Preterm Infants
    NCT02784821
    Conditions:   Enterocolitis, Necrotizing;   Bacteremia;   Bronchopulmonary Dysplasia;   Intraventricular Hemorrhage;   Periventricular Leukomalacia;   Chronic Lung Disease;   Retinopathy of Prematurity;   Ileal Perforation
    Interventions:   Drug: Antibiotic;   Other: Gastric fluid;   Other: Breast milk;   Other: Stool samples;   Drug: Antibiotics - pre-emptive;   Other: Skin swabs
    Sponsors:   University of Florida;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   Society for Pediatric Dermatology
    Completed
  • STAND Community Trial
    NCT02694939
    Condition:   Attention Deficit Hyperactivity Disorder
    Interventions:   Behavioral: STAND (Behavior Therapy + Motivational Interviewing);   Behavioral: Usual Care
    Sponsor:   Florida International University
    Active, not recruiting
  • Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 4)
    NCT02691182
    Condition:   Attention Deficit Hyperactivity Disorder (ADHD)
    Intervention:   Drug: SPN-810
    Sponsor:   Supernus Pharmaceuticals, Inc.
    Recruiting
  • JUEGA: A Fun Study for Hispanic/Latino Adolescent Girls
    NCT02578147
    Condition:   Adolescent Behavior
    Interventions:   Behavioral: Mighty Girls;   Behavioral: Game Girls
    Sponsors:   University of Miami;   National Institute of Nursing Research (NINR)
    Terminated
  • Intervention for Teens With ADHD and Substance Use
    NCT02502799
    Condition:   Attention Deficit Hyperactivity Disorder
    Interventions:   Behavioral: Brief Early Intervention;   Behavioral: Parent Training with Adolescent Cognitive Behavioral Therapy;   Drug: Methylphenidate
    Sponsor:   Florida International University
    Recruiting
  • Respiratory Muscle Function in Untreated X-Linked Myotubular Myopathy (XLMTM)
    NCT02453152
    Condition:   X-linked Myotubular Myopathy
    Interventions:   Other: History and physical;   Other: Tidal breathing;   Other: Maximal respiratory pressures;   Other: Peak cough flow;   Other: Pediatric Evaluation of Disability Inventory;   Other: PedsQL Multidimensional Fatigue Scale;   Other: Review of ventilation requirements
    Sponsors:   University of Florida;   Audentes Therapeutics
    Completed
  • A Within Subjects Comparison of Two Antegrade Flushing Regimens in Children
    NCT02435069
    Conditions:   Fecal Incontinence;   Neurogenic Bowel
    Interventions:   Drug: Dose Response - NS and USP Glycerin - First Intervention;   Drug: Effectiveness - NS and USP Glycerin - Second Intervention
    Sponsors:   Nemours Children's Clinic;   University of Florida
    Completed
  • Improving Medication Adherence in ADHD Adolescents
    NCT02271880
    Condition:   ADHD
    Interventions:   Other: Medication as usual;   Other: STAR
    Sponsor:   Florida International University
    Terminated
  • Assessment of Cardiopulmonary Function in Duchenne Muscular Dystrophy
    NCT02195999
    Condition:   Muscular Dystrophy, Duchenne
    Interventions:   Other: Magnetic Resonance Imaging (MRI);   Other: Pulmonary Function Testing (PFT);   Other: Metabolic Exercise Testing using stationary bicycle;   Other: Echocardiogram
    Sponsors:   University of Florida;   CureDuchenne
    Completed
  • Acupuncture in Neonatal Abstinence Syndrome (NAS) Babies
    NCT02062151
    Condition:   Neonatal Abstinence Syndrome
    Intervention:   Other: Acupuncture
    Sponsor:   University of South Florida
    Completed
  • Examining Tolerance to CNS Stimulants in ADHD
    NCT02039908
    Condition:   Attention-deficit/Hyperactivity Disorder
    Intervention:   Drug: Methylphenidate
    Sponsor:   Florida International University
    Active, not recruiting
  • Early Detection of Progressive Kidney Disease in Preterm Infants
    NCT02000895
    Conditions:   Kidney Disease;   Cardiovascular Disease
    Intervention:  
    Sponsor:   University of Miami
    Recruiting
  • Early iNO for Oxidative Stress, Vascular Tone and Inflammation in Babies With Hypoxic Respiratory Failure
    NCT01891500
    Conditions:   Persistent Fetal Circulation Syndrome;   Hypertension, Pulmonary, of Newborn, Persistent;   Persistent Pulmonary Hypertension of Newborn
    Interventions:   Drug: Inhaled nitric oxide;   Drug: Nitrogen Gas;   Drug: Crossover iNO
    Sponsors:   University of Florida;   Mallinckrodt
    Recruiting
  • Parent Educational Program for Children With Sickle Cell Disease
    NCT00860782
    Conditions:   Hemoglobin SC Disease;   Anemia, Sickle Cell
    Intervention:   Behavioral: Parent Educational Support
    Sponsors:   University of Miami;   National Heart, Lung, and Blood Institute (NHLBI)
    Active, not recruiting
  • Sleep and Emotional Memory in Peripubertal Anxiety
    NCT03643848
    Condition:   Anxiety
    Interventions:   Behavioral: Sleep with Sound Cues;   Behavioral: Sleep with Sham Cues
    Sponsor:   Florida International University
    Recruiting
  • Exposure Therapy for Auditory Sensitivity in Autism
    NCT03206996
    Conditions:   Sensory Disorders;   Autism;   Autism Spectrum Disorder;   Autism With High Cognitive Abilities;   Autistic Behavior;   Hyperacusis
    Interventions:   Behavioral: Exposure therapy;   Behavioral: Psycho-education;   Behavioral: Caregiver education/home program development
    Sponsor:   University of Florida
    Completed
  • Combination of Acetaminophen and Ibuprofen in the Management of Patent Ductus Arteriosus
    NCT03103022
    Conditions:   Patent Ductus Arteriosus;   Neonate
    Interventions:   Drug: Acetaminophen;   Drug: ibuprofen
    Sponsor:   University of Florida
    Completed
  • Human Fibrinogen Concentrate in Pediatric Cardiac Surgery
    NCT02822599
    Conditions:   Hypofibrinogenemia;   Afibrinogenemia;   Bleeding Disorders
    Interventions:   Drug: RiaStAP;   Drug: Saline
    Sponsor:   Nicklaus Children's Hospital f/k/a Miami Children's Hospital
    Completed
  • BIO-11006 for Osteosarcoma and Ewing's Sarcoma Lung Metastases
    NCT04183062
    Conditions:   Osteosarcoma Metastatic;   Ewing's Sarcoma Metastatic
    Intervention:   Drug: Chemotherapy (gemcitabine & docetaxel) plus BIO-11006
    Sponsor:   Nicklaus Children's Hospital f/k/a Miami Children's Hospital
    Recruiting
  • Development of Novel Biomarkers for the Early Diagnosis of Type 1 Diabetes
    NCT04164966
    Condition:   Type 1 Diabetes
    Intervention:  
    Sponsor:   Translational Research Institute for Metabolism and Diabetes, Florida
    Not yet recruiting
  • Effects of Platelet Rich Plasma Injections on Biomarkers After Anterior Cruciate Ligament Tears
    NCT04088227
    Conditions:   Anterior Cruciate Ligament Tear;   Anterior Cruciate Ligament Rupture
    Interventions:   Drug: Experimental Group;   Other: Control Group
    Sponsor:   Andrews Research & Education Foundation
    Recruiting
  • Prosthetic Device in Children With Upper Congenital Limb Deficiency
    NCT04059107
    Condition:   Upper Limb Deformities, Congenital
    Intervention:   Device: 3D Printed Myoelectric Prosthetic Device
    Sponsors:   Oregon Health and Science University;   Limbitless Solutions;   University of Central Florida
    Enrolling by invitation
  • Investigating Event-Related Potentials and Eye-Tracking Measures in Hockey Players
    NCT03975023
    Conditions:   Healthy;   Traumatic Brain Injury
    Intervention:   Device: NeuroCatch Platform (NCP)
    Sponsors:   Frederick Carrick, PhD, FACCN;   HealthTech Connex Inc.
    Recruiting
  • Observational Trial of the Impact of Radiation Dose in Children With Brain and Skull Base Tumors.
    NCT03972514
    Conditions:   Brain Tumor;   Brain Cancer;   Skull Base Tumor
    Intervention:  
    Sponsor:   Baptist Health South Florida
    Recruiting
  • Lactobacillus Johnsonii in Children and Adolescents With T1D
    NCT03961854
    Condition:   Type 1 Diabetes (T1D)
    Interventions:   Drug: L. johnsonii Probiotic;   Drug: Placebo Capsule
    Sponsors:   University of Florida;   Juvenile Diabetes Research Foundation
    Recruiting
  • Ex Vivo Drug Sensitivity Testing and Mutation Profiling
    NCT03860376
    Conditions:   Recurrent Childhood Acute Myeloid Leukemia;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Childhood Large Cell Lymphoma;   Refractory Childhood Acute Lymphoblastic Leukemia;   Refractory Childhood Hodgkin Lymphoma;   Refractory Childhood Malignant Germ Cell Neoplasm;   Recurrent Childhood Brain Tumor;   Recurrent Childhood Brainstem Glioma;   Recurrent Childhood Rhabdomyosarcoma;   Recurrent Childhood Soft Tissue Sarcoma;   Recurrent Childhood Ependymoma;   Recurrent Childhood Lymphoblastic Lymphoma;   Recurrent Childhood Gliosarcoma;   Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    Intervention:  
    Sponsors:   Florida International University;   Nicklaus Children's Hospital f/k/a Miami Children's Hospital
    Recruiting
  • Vorinostat Dose-escalation After Allogeneic Hematopoietic Cell Transplantation
    NCT03843528
    Conditions:   Acute Myeloid Leukemia;   Myelodysplastic Syndromes;   Mixed Phenotype Acute Leukemia;   Juvenile Myelomonocytic Leukemia
    Interventions:   Drug: Vorinostat;   Drug: Azacitidine Injection
    Sponsor:   Johns Hopkins All Children's Hospital
    Recruiting
  • Diabetes Autoimmunity Withdrawn in New Onset Patients (DAWN)
    NCT03794973
    Condition:   Diabetes Mellitus, Type 1
    Interventions:   Biological: TOL-3021;   Other: TOL-3021 Placebo
    Sponsor:   Tolerion, Inc.
    Not yet recruiting
  • Computer Assisted Family Intervention to Treat Self-Harm Disparities in Latinas and Sexual/Gender Minority Youth
    NCT03709472
    Conditions:   Self Harm;   Depression;   Emotion Dysregulation;   Behavior Problem
    Interventions:   Behavioral: Computer Assisted CIFFTA;   Behavioral: Behavioral: Traditional face-to-face treatment-no technology
    Sponsors:   University of Miami;   National Institute on Minority Health and Health Disparities (NIMHD)
    Recruiting
  • Training Language and Literacy for Children Who Use CIs
    NCT03582566
    Condition:   Hearing Loss, Sensorineural
    Interventions:   Behavioral: Phonological Awareness;   Behavioral: Working Memory;   Behavioral: Phonological Awareness + Working Memory;   Behavioral: Active Control
    Sponsors:   Florida State University;   Northwestern University
    Recruiting
  • Comparing Speedlyte and IV Rehydration Treating Children With Gastroenteritis in a Pediatric Emergency Department (ED)
    NCT03562702
    Conditions:   Dehydration;   Acute Gastroenteritis
    Interventions:   Other: Standard IV Rehydration Therapy;   Other: Oral Rehydration Therapy (ORT)
    Sponsors:   Nicklaus Children's Hospital f/k/a Miami Children's Hospital;   Einsoff Biohealth
    Recruiting
  • Type 2 Diabetes and the Brain in Adolescents
    NCT03461510
    Conditions:   Type 2 Diabetes Mellitus;   Obesity;   Pediatric Obesity;   Insulin Resistance;   Dysglycemia;   Hyperglycemia
    Interventions:   Procedure: Hyperglycemic clamp;   Procedure: Hyperinsulinemic Euglycemic clamp
    Sponsor:   Nemours Children's Clinic
    Completed
  • Diagnostic Odyssey: Whole Genome Sequencing (WGS)
    NCT03458962
    Conditions:   Genetic Disease;   Genetic Syndrome
    Intervention:   Genetic: Genetic Enrollees
    Sponsors:   Nicklaus Children's Hospital f/k/a Miami Children's Hospital;   Rady Pediatric Genomics & Systems Medicine Institute
    Enrolling by invitation
  • Study of Stool Patterns to Collect a Panel of Stool Images for the Development of a Software
    NCT03402555
    Condition:   Healthy
    Intervention:   Other: Stool pattern
    Sponsors:   Danone Asia Pacific Holdings Pte, Ltd.;   ObvioHealth
    Active, not recruiting
  • Microdystrophin Gene Transfer Study in Adolescents and Children With DMD
    NCT03368742
    Condition:   Duchenne Muscular Dystrophy
    Intervention:   Genetic: SGT-001
    Sponsor:   Solid Biosciences, LLC
    Suspended
  • Adoptive Cellular Therapy in Pediatric Patients With High-grade Gliomas
    NCT03334305
    Condition:   Malignant Glioma
    Interventions:   Biological: TTRNA-DC vaccines with GM-CSF;   Drug: Dose-intensified TMZ;   Biological: Autologous Hematopoietic Stem cells (HSCs);   Biological: TTRNA-xALT;   Drug: Td vaccine
    Sponsors:   University of Florida;   National Pediatric Cancer Foundation;   National Cancer Institute (NCI);   Moffitt Clinical Research Network (MCRN);   National Institutes of Health (NIH)
    Recruiting
  • Ketogenic Diet in Children With Malignant or Recurrent/Refractory Brain Tumor
    NCT03328858
    Condition:   Brain Tumors
    Intervention:   Other: Ketogenic Diet
    Sponsor:   Nicklaus Children's Hospital f/k/a Miami Children's Hospital
    Active, not recruiting
  • Wellness Achieved Through Changing Habits (The WATCH Study)
    NCT03284788
    Conditions:   Weight Loss;   Obesity;   Overweight
    Intervention:   Behavioral: ABT Weight Loss Intervention
    Sponsors:   University of Florida;   StayWell;   National Heart, Lung, and Blood Institute (NHLBI);   WellCare Health Plans, Inc.
    Recruiting
  • Skeletal Muscle and Adipose Tissue Study
    NCT03190668
    Condition:   Idiopathic Scoliosis
    Interventions:   Drug: Bolus dose of Cefazolin;   Drug: Continuous Cefazolin drip;   Device: Paraspinal muscle microdialysis catheters;   Device: Subcutaneous microdialysis catheters
    Sponsor:   University of Florida
    Recruiting
  • Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With ADHD
    NCT03638466
    Condition:   Attention Deficit Hyperactivity Disorder (ADHD)
    Interventions:   Drug: SPN-810;   Drug: Placebo
    Sponsor:   Supernus Pharmaceuticals, Inc.
    Terminated
  • Steroids in Children Hospitalized With Asthma
    NCT02780479
    Conditions:   Asthma;   Status Asthmaticus;   Wheezes
    Interventions:   Drug: Dexamethasone;   Drug: Prednisone
    Sponsor:   University of Florida
    Terminated
  • Strata Programmable CSF Shunt Valve Study
    NCT02737163
    Condition:   Hydrocephalus
    Intervention:  
    Sponsor:   Johns Hopkins All Children's Hospital
    Terminated
  • Influence of Monopoly Game on Subtle Behaviors
    NCT02729389
    Conditions:   Psychosocial Influence on Cardiovascular Disease;   Cardiovascular Disease
    Interventions:   Behavioral: High Social Status Condition;   Behavioral: Low Social Status Condition
    Sponsors:   University of Florida;   University of Alabama at Birmingham;   Brown University
    Completed
  • Advancing Child Competencies by Extending Supported Services (ACCESS) for Families Program
    NCT03260816
    Conditions:   Developmental Delay;   Disruptive Behavior
    Interventions:   Behavioral: Internet-delivered Parent-Child Interaction Therapy (I-PCIT);   Other: Referrals as Usual (RAU)
    Sponsors:   Florida International University;   University of Miami;   Nicklaus Children's Hospital f/k/a Miami Children's Hospital;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Active, not recruiting
  • Phase II Study of Intraventricular Methotrexate in Children With Recurrent or Progressive Malignant Brain Tumors
    NCT02684071
    Conditions:   Recurrent Childhood Medulloblastoma;   Recurrent Childhood Ependymoma;   Childhood Atypical Teratoid/Rhabdoid Tumor;   Embryonal Tumor With Abundant Neuropil and True Rosettes;   Metastatic Malignant Neoplasm to the Leptomeninges
    Interventions:   Drug: Intra thecal methotrexate;   Drug: topotecan;   Drug: cyclophosphamide
    Sponsor:   Nicklaus Children's Hospital f/k/a Miami Children's Hospital
    Active, not recruiting
  • Safety, Efficacy, and Feasibility of High-dose Cholecalciferol in Pediatric Patients With Cystic Fibrosis
    NCT02613884
    Condition:   Vitamin D Deficiency
    Intervention:   Drug: Treatment
    Sponsor:   Johns Hopkins All Children's Hospital
    Completed
  • Novel Mechanisms and Approaches to Treat Neonatal Sepsis
    NCT02554630
    Conditions:   Complication of Prematurity;   Immunologic Deficiency Syndromes
    Interventions:   Other: Adjuvant;   Other: Blood Collection
    Sponsors:   University of Florida;   National Institute of General Medical Sciences (NIGMS);   Surgical Infection Society
    Recruiting
  • The OneFlorida Cancer Control Alliance: Implementing the 6As in Pediatric Primary Care
    NCT03044691
    Condition:   Smoking Cessation
    Intervention:   Behavioral: ResearchACTS software
    Sponsor:   University of Florida
    Terminated
  • Anesthetic Optimization in Scoliosis Surgery
    NCT02481570
    Conditions:   Adolescent Idiopathic Scoliosis;   Respiratory Depression;   Postoperative Pain
    Intervention:   Other: pharmacokinetic simulation
    Sponsor:   University of Florida
    Completed
  • Diet and Exercise in Pompe Disease
    NCT02363153
    Conditions:   Pompe Disease;   Glycogen Storage Disease Type II;   Lysosomal Storage Diseases
    Intervention:   Other: Diet and Exercise
    Sponsors:   University of Florida;   Amicus Therapeutics
    Recruiting
  • Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
    NCT02216500
    Condition:   Seizures
    Intervention:   Dietary Supplement: Ketogenic Therapy
    Sponsor:   University of Florida
    Recruiting
  • Targeting Attention Orienting to Social Threat to Reduce Social Anxiety in Youth
    NCT03932032
    Condition:   Social Anxiety Disorder of Childhood
    Interventions:   Behavioral: Attention Bias Modification Treatment;   Behavioral: Neutral Control Task
    Sponsors:   Florida International University;   Yale University
    Recruiting
  • Autologous Stem Cell Transplantation for Patients With Recurrent Nasopharyngeal Carcinoma
    NCT02137096
    Condition:   Recurrent Nasopharynx Carcinoma
    Interventions:   Drug: Etoposide phosphate;   Drug: Carboplatin;   Drug: Ifosfamide;   Procedure: Autologous Stem Cell Transplantation
    Sponsor:   University of Florida
    Terminated
  • Open-Label Safety and PK Study of ER Hydromorphone Tablets in Opioid-Tolerant Pediatric Chronic Pain Patients
    NCT02321319
    Condition:   Chronic Pain
    Intervention:   Drug: Hydromorphone HCl ER Tablets
    Sponsor:   Mallinckrodt
    Terminated
  • Attention Training to Modify Error-related Negativity and Risk for Anxiety in Adolescence
    NCT03176004
    Condition:   Anxiety
    Intervention:   Other: Attention Bias Modification
    Sponsors:   Florida State University;   San Diego State University
    Recruiting
  • Proteinuria in Pre and Post Transplant
    NCT01094327
    Condition:   Proteinuria
    Intervention:  
    Sponsor:   University of Miami
    Recruiting
  • Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors
    NCT00876993
    Condition:   Central Nervous System Tumors
    Interventions:   Drug: Bevacizumab;   Drug: Irinotecan;   Drug: Temozolomide
    Sponsors:   Johns Hopkins All Children's Hospital;   V Foundation;   Brain Tumor Alliance
    Completed
  • Early Administration of Steroids in the Ambulance Setting
    NCT03962894
    Condition:   Asthma in Children
    Intervention:   Drug: Prednisolone
    Sponsor:   University of Florida
    Recruiting
  • Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Focal Radiotherapy Recovery Alone or With Dose-intensified Temozolomide (Phase I)
    NCT03396575
    Condition:   Diffuse Intrinsic Pontine Glioma (DIPG)
    Interventions:   Biological: TTRNA-DC vaccines with GM-CSF;   Biological: TTRNA-xALT;   Drug: Cyclophosphamide + Fludarabine Lymphodepletive Conditioning;   Drug: Dose-Intensified TMZ;   Drug: Td vaccine;   Biological: Autologous Hematopoietic Stem Cells (HSC)
    Sponsors:   University of Florida;   Accelerate Brain Cancer Cure;   Lyla Nsouli Foundation
    Recruiting
  • Pevonedistat With VXLD Chemotherapy for Adolescent/Young Adults With Relapsed/Refractory Acute Lymphoblastic Leukemia
    NCT03349281
    Conditions:   Refractory Acute Lymphoblastic Leukemia;   Relapsed Acute Lymphoblastic Leukemia
    Interventions:   Drug: Pevonedistat;   Drug: Vincristine;   Drug: Dexamethasone;   Drug: PEG-asparaginase;   Drug: Doxorubicin;   Drug: Cytarabine;   Drug: Methotrexate;   Drug: Hydrocortisone
    Sponsors:   Julio Barredo;   Takeda
    Recruiting
  • Normative Oculomotor and Vestibular Data in Pediatric Population
    NCT04107610
    Condition:   Healthy
    Intervention:   Device: I-PAS
    Sponsors:   Neuro Kinetics;   Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute);   University of Miami
    Not yet recruiting
  • Nab-paclitaxel in Combination With Gemcitabine for Pediatric Relapsed and Refractory Solid Tumors
    NCT03507491
    Condition:   Cancer
    Interventions:   Drug: Gemcitabine;   Drug: Nab-paclitaxel
    Sponsors:   Emory University;   Celgene Corporation
    Recruiting
  • Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors
    NCT02644291
    Conditions:   Medulloblastoma;   Astrocytoma, Grade III;   Glioblastoma;   Anaplastic Astrocytoma;   Brain Stem Neoplasms, Malignant;   Oligodendroblastoma;   Anaplastic Oligodendroglioma;   Malignant Glioma
    Intervention:   Drug: Mebendazole
    Sponsor:   Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Recruiting
  • A Phase II Trial of Limited Surgery and Proton Therapy for Craniopharyngioma or Observation After Radical Resection
    NCT01419067
    Condition:   Craniopharyngioma
    Interventions:   Procedure: Radical Surgery or Limited Surgery;   Device: Proton Therapy;   Drug: ^1^8F-fluorodeoxyglucose;   Drug: ^1^1C-methionine
    Sponsor:   St. Jude Children's Research Hospital
    Active, not recruiting
  • Community Study of Outcome Monitoring for Emotional Disorders in Teens
    NCT02567266
    Conditions:   Depression;   Anxiety
    Interventions:   Behavioral: Unified Protocol for Adolescents (UP-A);   Behavioral: Youth Outcomes Questionnaire;   Behavioral: Treatment as Usual
    Sponsors:   University of Miami;   University of Connecticut;   National Institute of Mental Health (NIMH)
    Recruiting
  • Computerized Cognitive Behavioral Therapy for Childhood Anxiety in Community Health Centers
    NCT01416805
    Conditions:   Generalized Anxiety Disorder;   Social Phobia;   Separation Anxiety Disorder
    Interventions:   Behavioral: Computerized Cognitive Behavioral Therapy;   Behavioral: Treatment as usual
    Sponsors:   University of South Florida;   Access Behavioral Health;   Henderson Behavioral Health;   Directions for Mental Health
    Completed
  • Superficial Radiation Therapy (SRT) for the Treatment of Recurrent Keloid Scars
    NCT04184011
    Condition:   Keloid Scar
    Intervention:   Device: SRT-100™
    Sponsor:   Sensus Healthcare
    Recruiting
  • Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to, Intolerant of, or Incomplete Responders to Omalizumab
    NCT04180488
    Condition:   Chronic Spontaneous Urticaria
    Interventions:   Drug: Dupilumab SAR231893;   Drug: Placebo;   Drug: non sedating H1-antihistamine
    Sponsors:   Sanofi;   Regeneron Pharmaceuticals
    Recruiting
  • Alpha-1 Research Registry
    NCT04157049
    Condition:   Alpha 1-Antitrypsin Deficiency
    Intervention:  
    Sponsor:   Alpha-1 Foundation
    Recruiting
  • To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Secondarily Infected Traumatic Skin Lesions
    NCT04155203
    Condition:   Secondarily Infected Traumatic Skin Lesions
    Interventions:   Drug: Mupirocin Calcium;   Drug: Vehicle
    Sponsor:   Perrigo Company
    Recruiting
  • Evaluation of Quality of Vision and Spectacle Independence With the AcrySof® Panoptix® Intraocular Lens
    NCT04124952
    Condition:   Cataract
    Intervention:   Device: Panoptix
    Sponsors:   SightTrust Eye Institute;   Science in Vision
    Enrolling by invitation
  • Enhancing School-Based Violence Prevention
    NCT04087772
    Condition:   Aggressive Childhood Behavior
    Interventions:   Behavioral: Mental Health Enhanced Positive Behavioral Interventions and Supports (PBIS-MH);   Behavioral: Racial/Ethnic Discrimination Interventions (RED)
    Sponsors:   Medical University of South Carolina;   National Institute on Minority Health and Health Disparities (NIMHD)
    Recruiting
  • Iron Absorption and Exercise
    NCT04079322
    Conditions:   Iron-deficiency;   Iron Deficiency Anemia
    Intervention:   Other: Meal
    Sponsor:   Florida State University
    Recruiting
  • Tissue Oxygen Deprivation as Detected With Raman in Association With Umbilical Artery Catheters
    NCT04038203
    Condition:   Tissue Oxygenation
    Intervention:   Device: Resonance Raman Spectroscopy (RPS)
    Sponsor:   University of Florida
    Not yet recruiting
  • Open-label Extension Study of Brazikumab in Crohn's Disease
    NCT03961815
    Condition:   Crohn's Disease
    Intervention:   Drug: Brazikumab
    Sponsor:   Allergan
    Enrolling by invitation
  • Home Video-based Telemedicine to Reduce Hypoglycemia Fear in Parents of Young Children
    NCT03914547
    Condition:   Type 1 Diabetes Mellitus
    Interventions:   Behavioral: REDCHiP;   Behavioral: ATTN
    Sponsors:   University of Kansas Medical Center;   Children's Mercy Hospital Kansas City;   University of Florida;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
    Recruiting
  • Evidence-based Assessment of Medication Sensitivity in Acute Hepatic Porphyria
    NCT03906214
    Condition:   Porphyrias
    Intervention:   Other: Web-based Survey
    Sponsors:   University of South Florida;   University of Texas;   Wake Forest University Health Sciences;   University of Miami;   University of Washington;   Icahn School of Medicine at Mount Sinai;   University of Alabama at Birmingham;   University of California, San Francisco;   University of Utah;   National Institutes of Health (NIH)
    Completed
  • Focused Cardiac Ultrasound
    NCT03887286
    Conditions:   Ventricular Dysfunction;   Pericardial Effusion;   Valvular Disease;   Septal Defect
    Interventions:   Device: Philips EPIQ 7 ultrasound machine;   Device: Philips Lumify Broadband sector array transducer
    Sponsor:   University of Miami
    Completed
  • The Loop Observational Study
    NCT03838900
    Condition:   Diabetes Mellitus, Type 1
    Intervention:   Device: Loop
    Sponsors:   Jaeb Center for Health Research;   Stanford University;   Tidepool Project;   RileyLink
    Active, not recruiting
  • A Study of S6G5T 3 in the Treatment of Acne Vulgaris
    NCT03761810
    Condition:   Acne Vulgaris
    Interventions:   Drug: S6G5T-3;   Drug: S6G5T-8
    Sponsor:   Sol-Gel Technologies, Ltd.
    Recruiting
  • The Effect Of An Anesthetic Procedure On Post Operative Pain Management In Carpal Tunnel Release
    NCT03729375
    Conditions:   Pain, Postoperative;   Carpal Tunnel Syndrome
    Interventions:   Drug: 10cc injection of bupivacaine;   Drug: 20cc injection of bupivacaine
    Sponsor:   University of South Florida
    Recruiting
  • A Study for a Topical Medication Versus Placebo in Patients With Hand Dermatitis
    NCT03703895
    Condition:   Hand Dermatitis
    Interventions:   Drug: Topical AFX5931;   Drug: Topical Placebo
    Sponsors:   The Center for Clinical and Cosmetic Research;   Afecta Pharmaceuticals
    Completed
  • Diagnostic Odyssey Survey 2
    NCT03678740
    Condition:   Mitochondrial Diseases
    Intervention:   Other: Odyssey 2 Survey
    Sponsors:   University of South Florida;   Columbia University;   United Mitochondrial Disease Foundation;   George Washington University;   Massachusetts General Hospital
    Completed
  • Omegaven as Alternative Parenteral Fat Nutrition
    NCT03662282
    Conditions:   Cholestasis;   Cholestasis of Parenteral Nutrition
    Intervention:   Drug: Omegaven
    Sponsor:   University of South Florida
    Completed
  • Mission Reconnect- Delivering a Mobile and Web Based Self Directed Complementary And Integrative Health Program to Veterans and Their Partners to Manage Pain and PTSD
    NCT03593772
    Conditions:   PTSD;   Chronic Musculoskeletal Pain
    Intervention:   Behavioral: Mission Reconnect
    Sponsor:   VA Office of Research and Development
    Recruiting
  • Adhear Bone Conduction System
    NCT03533686
    Conditions:   Hearing Loss, Conductive;   Hearing Loss, Unilateral
    Interventions:   Device: Adhear Bone Conduction System;   Device: Standard of Care
    Sponsors:   University of Miami;   Med-El Corporation
    Recruiting
  • Pilot Study of OMEGA-3 and Vitamin D in High-Dose in Type I Diabetic Patients
    NCT03406897
    Conditions:   Diabetes Mellitus, Type 1;   Hypoglycemia;   Diabetes Mellitus;   Diabetes, Autoimmune
    Interventions:   Drug: Cholecalciferol;   Drug: Omega 3 fatty acid
    Sponsors:   Rodolfo Alejandro;   Diabetes Research Institute Foundation
    Recruiting
  • A Study to Assess the Safety and Local Tolerability of DFD-03 (Tazarotene) Lotion, 0.1% Compared to Tazorac® (Tazarotene) Cream, 0.1% in the Topical Treatment of Acne Vulgaris
    NCT03341910
    Condition:   Acne Vulgaris
    Interventions:   Drug: Tazarotene Lotion, 0.1%;   Drug: Tazarotene Cream, 0.1%;   Drug: Vehicle Lotion 0%;   Drug: Vehicle Cream 0%
    Sponsor:   Dr. Reddy's Laboratories Limited
    Completed
  • Clinical Endpoint Study of Ivermectin 0.5% Lotion
    NCT03301649
    Condition:   Head Lice
    Interventions:   Drug: Ivermectin Lotion 0.5%;   Drug: Placebo/Vehicle Lotion
    Sponsor:   Actavis Inc.
    Completed
  • Friends/Family in the Abortion Procedure Room (FAIR)
    NCT03227614
    Conditions:   Anxiety;   Pain;   Abortion
    Intervention:   Behavioral: Support Person Intervention
    Sponsor:   Planned Parenthood of Southwest and Central Florida
    Completed
  • Clinical Applications of Advanced Ophthalmic Imaging
    NCT03135327
    Conditions:   Multiple Sclerosis;   Dry Eye Syndromes;   Diabetic Retinopathy;   Presbyopia;   Myopia;   Dementia
    Intervention:   Other: No intervention
    Sponsor:   University of Miami
    Recruiting
  • Pregnancy in Osteogenesis Imperfecta (OI) Registry
    NCT03072303
    Conditions:   Osteogenesis Imperfecta;   Brittle Bone Disorders
    Intervention:   Other: Web-based Survey
    Sponsors:   University of South Florida;   Rare Diseases Clinical Research Network;   National Institutes of Health (NIH)
    Completed
  • Topical BPM31510 3.0% Cream in Patients With Epidermolysis Bullosa
    NCT02793960
    Condition:   Epidermolysis Bullosa
    Intervention:   Drug: topical BPM31510 3.0% Cream
    Sponsors:   Shasa Hu;   Berg, LLC
    Active, not recruiting
  • Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas
    NCT02636725
    Conditions:   Alveolar Soft Part Sarcoma;   Soft Tissue Sarcomas
    Interventions:   Drug: Axitinib;   Drug: Pembrolizumab;   Procedure: Blood Draw;   Procedure: Tumor Specimen Collection
    Sponsors:   Jonathan Trent;   Merck Sharp & Dohme Corp.;   Pfizer
    Active, not recruiting
  • Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD
    NCT02578030
    Condition:   Attention-Deficit Hyperactivity Disorder (ADHD)
    Interventions:   Drug: SHP465 12.5mg;   Drug: SHP465 25mg
    Sponsor:   Shire
    Completed
  • Biomarkers in Friedreich's Ataxia
    NCT02497534
    Condition:   Friedreich's Ataxia
    Intervention:  
    Sponsors:   University of Florida;   Children's Miracle Network;   National Institutes of Health (NIH);   Friedreich's Ataxia Research Alliance
    Recruiting
  • Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and Adolescents
    NCT02402933
    Conditions:   Hypoglycemia;   Diabetes Mellitus
    Intervention:   Drug: Nasal Glucagon
    Sponsor:   Eli Lilly and Company
    Completed
  • Electroencephalogram (EEG) Triggered Functional Magnetic Resonance Imaging (fMRI) in Epilepsy Patients
    NCT02193932
    Condition:   Epilepsy
    Intervention:   Other: EEG Triggered fMRI using Micro Maglink
    Sponsor:   Baptist Health South Florida
    Completed
  • VCRC Patient Contact Registry Patient-Reported Data Validation Study
    NCT02190942
    Conditions:   Behcet's Disease;   Churg-Strauss Syndrome;   Giant Cell Arteritis;   Wegener Granulomatosis;   Microscopic Polyangiitis;   Polyarteritis Nodosa;   Takayasu's Arteritis
    Intervention:  
    Sponsors:   University of South Florida;   Wayne State University;   University of Pittsburgh;   University of Pennsylvania;   Boston University
    Completed
  • Reducing Hospitalizations of Nursing Home Residents
    NCT02177058
    Condition:   Unnecessary Hospitalizations of Nursing Home Residents
    Interventions:   Other: INTERACT Quality improvement program;   Other: Quarterly surveys/data reporting
    Sponsors:   Florida Atlantic University;   National Institute of Nursing Research (NINR);   University of Minnesota
    Active, not recruiting
  • Safety Study of an Adeno-associated Virus Vector for Gene Therapy of Leber's Hereditary Optic Neuropathy
    NCT02161380
    Condition:   Leber's Hereditary Optic Neuropathy
    Interventions:   Drug: injection of scAAV2-P1ND4v2 1.18x10e9 vg (Low),;   Drug: injection of scAAV2-P1ND4v2 5.81 X10e9 vg (Med);   Drug: injection of scAAV2-P1ND4v2 2.4 X10e10vg (High);   Drug: injection of scAAV2-P1ND4v2 1.0 X10e11vg (Higher)
    Sponsors:   John Guy;   National Eye Institute (NEI)
    Recruiting
  • Deep Brain Stimulation Effects on Gait and Balance in Patients With Parkinson's Disease
    NCT02022735
    Condition:   Parkinson's Disease
    Intervention:   Device: Deep Brain Stimulation
    Sponsor:   University of Miami
    Active, not recruiting
  • The Preeclampsia Registry
    NCT02020174
    Conditions:   Preeclampsia;   Eclampsia;   HELLP Syndrome;   Toxemia;   Hypertensive Disorder of Pregnancy
    Intervention:  
    Sponsor:   Preeclampsia Foundation
    Recruiting
  • Liver Fibrosis in Sickle Cell Disease
    NCT02007746
    Condition:   Sickle Cell Disease
    Interventions:   Other: Liver transient elastography (Fibroscan);   Other: Ferriscan;   Procedure: Liver biopsy in iron overloaded subjects.
    Sponsor:   University of Miami
    Recruiting
  • Blinded, Randomized Study Evaluating Aurstat Versus Control in the Treatment of Atopic Dermatitis Associated Pruritus
    NCT01905631
    Conditions:   Pruritus;   Atopic Dermatitis
    Intervention:   Drug: Aurstat Anti-Itch Hydrogel (Aurstat)
    Sponsors:   The Center for Clinical and Cosmetic Research;   Onset Dermatologics, Inc.
    Completed
  • Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma
    NCT01808820
    Conditions:   Malignant Glioma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma;   High Grade Glioma
    Interventions:   Biological: Dendritic Cell Vaccine;   Biological: Tumor Lysate;   Other: Imiquimod;   Procedure: Leukapheresis
    Sponsor:   Macarena De La Fuente
    Active, not recruiting
  • Dendritic Cell Vaccine With or Without Gemcitabine Pre-Treatment for Adults and Children With Sarcoma
    NCT01803152
    Conditions:   Sarcoma;   Soft Tissue Sarcoma;   Bone Sarcoma
    Interventions:   Biological: Dendritic Cells Vaccine;   Biological: Lysate of Tumor;   Drug: Gemcitabine;   Drug: Imiquimod;   Procedure: Leukapheresis
    Sponsor:   Macarena De La Fuente
    Active, not recruiting
  • Evaluation of Adrenal Suppression Potential and Pharmacokinetics of Halobetasol Lotion 0.05%
    NCT03212963
    Condition:   Plaque Psoriasis
    Intervention:   Drug: Halobetasol Topical Lotion
    Sponsor:   Sun Pharmaceutical Industries Limited
    Completed
  • Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV Melanoma
    NCT01176474
    Condition:   Melanoma (Skin)
    Interventions:   Biological: NY-ESO-1 157-165 (165V);   Drug: Nivolumab;   Biological: gp100:280-288 (288V);   Drug: Montanide ISA 51 vegetable grade (VG);   Drug: Ipilimumab;   Procedure: Apheresis Procedure
    Sponsors:   H. Lee Moffitt Cancer Center and Research Institute;   National Cancer Institute (NCI);   Medarex;   Bristol-Myers Squibb
    Active, not recruiting
  • Multiple Class I Peptides & Montanide ISA 51 VG w Escalating Doses of Anti-PD-1 ab BMS936558
    NCT01176461
    Condition:   Melanoma (Skin)
    Interventions:   Biological: MART-1;   Biological: NY-ESO-1;   Biological: gp100:209-217(210M);   Biological: gp100:280-288(288V);   Drug: Montanide ISA 51 VG;   Biological: BMS-936558
    Sponsors:   H. Lee Moffitt Cancer Center and Research Institute;   National Cancer Institute (NCI);   Bristol-Myers Squibb;   Medarex
    Active, not recruiting
  • The Insulin-Only Bionic Pancreas Bridging Study- Pediatric Transitional Study
    NCT04112069
    Condition:   Type1 Diabetes Mellitus
    Interventions:   Device: iLet Bionic Pancreas insulin-only configuration with Humalog or Novolog;   Other: Usual Care
    Sponsor:   Massachusetts General Hospital
    Completed
  • Kuvan Therapy in Phenylketonuria (PKU): The Effect of Blood Phenylalanine Concentration on Kuvan Response
    NCT00841100
    Condition:   Phenylketonuria
    Interventions:   Drug: Kuvan;   Other: Diet
    Sponsor:   University of Miami
    Completed
  • Florida Center for Brain Tumor Research
    NCT00811148
    Condition:   Brain Tumors
    Intervention:   Procedure: Tissue Bank
    Sponsor:   University of Florida
    Recruiting
  • Biomechanics/Motion Analysis Laboratory Data Bank
    NCT00160771
    Condition:   Kinematics
    Intervention:   Behavioral: Joint Motion Analysis
    Sponsor:   University of Florida
    Recruiting
  • Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
    NCT00005792
    Conditions:   Multiple Myeloma;   Plasma Cell Neoplasm
    Interventions:   Drug: etoposide phosphate;   Drug: melphalan;   Drug: topotecan;   Procedure: Autologous Stem Cell Rescue
    Sponsors:   H. Lee Moffitt Cancer Center and Research Institute;   SmithKline Beecham;   Bristol-Myers Squibb
    Completed
  • Adaptive Response to Intervention (RTI) for Students With ADHD
    NCT03511976
    Condition:   Attention Deficit Disorder With Hyperactivity
    Interventions:   Behavioral: Tier 1 Classroom Management;   Behavioral: Daily Report Card (DRC);   Behavioral: Enhanced DRC (DRC-E);   Drug: Stimulant
    Sponsors:   Florida International University;   University at Buffalo
    Recruiting
  • Non-Invasive Detection of Tissue Oxygen Deprivation in Premature Infants With Patent Ductus Arteriosus.
    NCT03277768
    Conditions:   Premature Infant;   Patent Ductus Arteriosus;   Hemodynamic Instability
    Intervention:   Device: Resonance Raman Spectroscopy (RRS)
    Sponsors:   University of Florida;   Boston Children’s Hospital
    Completed
  • A Study to Assess the Effectiveness of the Nautilus BrainPulse™ as an Aid in the Diagnosis of Concussion
    NCT02660164
    Condition:   Concussion
    Intervention:   Device: Nautilus BrainPulse Recording
    Sponsor:   Jan Medical, Inc.
    Recruiting
  • Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR
    NCT02443805
    Conditions:   Rhinitis, Allergic, Perennial;   House Dust Mite Allergy
    Interventions:   Biological: 300 IR;   Biological: Placebo
    Sponsor:   Stallergenes Greer
    Completed
  • Incorporating teleCBIT Into a Hospital-Based Tic Program
    NCT04007913
    Conditions:   Tic Disorders;   Tourette Syndrome
    Intervention:   Behavioral: teleCBIT
    Sponsors:   San Jose State University;   American Academy of Neurology;   Tourette Association of America
    Completed
  • Investigation of Neurocognitive Measures of Sport-Related Injury
    NCT03414242
    Condition:   Concussion, Brain
    Intervention:   Other: Cervical spine musculature
    Sponsor:   Mayo Clinic
    Enrolling by invitation
  • Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy
    NCT01484678
    Condition:   Duchenne Muscular Dystrophy
    Intervention:  
    Sponsors:   University of Florida;   University of Pennsylvania;   Oregon Health and Science University;   Children's Hospital of Philadelphia;   Shriners Hospitals for Children;   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
    Recruiting
  • Phase I Trial of Gene Vector to Patients With Retinal Disease Due to RPE65 Mutations
    NCT00481546
    Conditions:   Amaurosis of Leber;   Retinal Diseases
    Intervention:   Genetic: rAAV2-CBSB-hRPE65
    Sponsors:   University of Pennsylvania;   National Eye Institute (NEI)
    Active, not recruiting
  • Vaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor
    NCT01326104
    Conditions:   Medulloblastoma;   Neuroectodermal Tumor
    Interventions:   Biological: TTRNA-xALT;   Biological: TTRNA-DCs
    Sponsors:   University of Florida;   United States Department of Defense
    Active, not recruiting
  • Reversing Type 1 Diabetes After it is Established
    NCT01106157
    Condition:   Diabetes Mellitus, Type 1
    Interventions:   Drug: Anti-Thymocyte Globin (ATG);   Drug: Placebo;   Drug: Pegylated GCSF
    Sponsors:   University of Florida;   The Leona M. and Harry B. Helmsley Charitable Trust;   Genzyme, a Sanofi Company
    Completed
  • Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy
    NCT01871766
    Condition:   Rhabdomyosarcoma
    Interventions:   Drug: Vincristine;   Drug: Dactinomycin;   Drug: Cyclophosphamide;   Procedure: Surgical Resection;   Procedure: Radiation;   Drug: Bevacizumab;   Drug: Sorafenib;   Drug: Myeloid Growth Factor;   Procedure: Lymph Node Sampling;   Drug: Irinotecan;   Drug: Ifosfamide;   Drug: Etoposide;   Drug: Etoposide Phosphate;   Drug: Doxorubicin;   Drug: Dexrazoxane;   Drug: ^1^1C-methionine
    Sponsor:   St. Jude Children's Research Hospital
    Recruiting
  • A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis
    NCT03987763
    Condition:   Psoriasis
    Intervention:   Drug: IDP-122 Lotion
    Sponsor:   Bausch Health Americas, Inc.
    Recruiting
  • A Study to Assess the Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of 2-Week Treatment With Inhaled AZD7594 in Adolescents (12 to 17 Years) With Asthma
    NCT03976869
    Condition:   Asthma
    Intervention:   Drug: AZD7594
    Sponsors:   AstraZeneca;   Parexel
    Recruiting
  • A Food Additive Removal Diet for Pediatric Eosinophilic Esophagitis
    NCT03657771
    Condition:   Eosinophilic Esophagitis
    Interventions:   Other: DED;   Other: FREE
    Sponsor:   Nemours Children's Clinic
    Recruiting
  • Glycemic Control and the Brain in Children With Type 1 Diabetes
    NCT03428932
    Condition:   Type 1 Diabetes Mellitus
    Intervention:   Device: Closed Loop (Medtronic 670G)
    Sponsors:   Nemours Children's Clinic;   National Institutes of Health (NIH);   Washington University School of Medicine;   Stanford University;   University of Iowa;   Yale University;   Jaeb Center for Health Research
    Completed
  • Remote Monitoring of Diabetes in Young Children With Type 1 Diabetes
    NCT02848261
    Condition:   Type 1 Diabetes Mellitus
    Interventions:   Behavioral: Developmental Demands;   Behavioral: Distress Reduction;   Behavioral: Remote Monitoring;   Behavioral: Fear of Hypoglycemia;   Behavioral: No intervention
    Sponsors:   Stanford University;   University of Colorado, Denver;   Indiana University;   University of South Florida
    Completed
  • Intense Physiotherapies to Improve Function in Young Children With Cerebral Palsy
    NCT02167022
    Condition:   Cerebral Palsy
    Intervention:   Other: Physical and occupational therapy
    Sponsors:   University of Arizona;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   Tucson Medical Center;   Phoenix Children's Hospital;   United Cerebral Palsy-Central Arizona;   Nemours Children's Hospital
    Active, not recruiting
  • Phase 1/2 Study in Boys With Duchenne Muscular Dystrophy
    NCT02439216
    Condition:   Muscular Dystrophy, Duchenne
    Interventions:   Drug: Edasalonexent;   Drug: Placebo
    Sponsor:   Catabasis Pharmaceuticals
    Completed
  • Implementing a Healthcare Provider Education Intervention in Rural Communities to Reduce Asthma Morbidity
    NCT04060823
    Condition:   Asthma
    Intervention:   Other: Easy Breathing program
    Sponsor:   University of Florida
    Recruiting
  • Teacher Child Interaction Training (TCIT): Randomized Control Trial
    NCT04000230
    Condition:   Behavior, Child
    Interventions:   Behavioral: TCIT;   Behavioral: Booster
    Sponsors:   University of Miami;   The Children's Trust
    Recruiting
  • Spanish Intervention for Caregivers of Veterans With Stroke
    NCT03142841
    Condition:   Depression
    Intervention:   Other: RESCUE Problem Solving Intervention
    Sponsor:   VA Office of Research and Development
    Recruiting
  • Intervention to Expand Opioid Use Disorder Treatment Pharmacotherapy Prescribers
    NCT02926482
    Condition:   Opioid-use Disorder
    Intervention:   Behavioral: Prescriber Recruitment Bundle (PRB)
    Sponsors:   University of Wisconsin, Madison;   National Institute on Drug Abuse (NIDA)
    Active, not recruiting
  • Statins in Children With Type 1 Diabetes and Hypercholesterolemia
    NCT01236365
    Conditions:   Diabetes Mellitus, Insulin-Dependent;   Hypercholesterolemia
    Interventions:   Drug: Atorvastatin;   Drug: Atorvastatin Placebo
    Sponsors:   Nemours Children's Clinic;   Pfizer;   Medtronic;   Quest Diagnostics
    Completed
  • A Phase 2 Study for Dose Determination of SRP-5051, Then Dose Expansion in Patients With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatment
    NCT04004065
    Condition:   Duchenne Muscular Dystrophy
    Intervention:   Drug: SRP-5051
    Sponsor:   Sarepta Therapeutics, Inc.
    Recruiting
  • Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma
    NCT03739372
    Conditions:   Glioma;   Glioma of Brain;   Cancer;   Pediatric Cancer;   Pediatric Brain Tumor;   Astrocytoma;   Glioblastoma;   Hemispheric
    Intervention:   Other: Specialized tumor board recommendation
    Sponsors:   University of California, San Francisco;   Pacific Pediatric Neuro-Oncology Consortium
    Recruiting
  • PRC-063 Classroom Study in Children (6-12 Years of Age) With ADHD
    NCT03172481
    Condition:   ADHD
    Interventions:   Drug: PRC-063 oral capsules;   Drug: Placebo oral capsules
    Sponsor:   Purdue Pharma, Canada
    Completed
  • Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies
    NCT03031938
    Conditions:   Osteoarthritis;   Cancer Pain;   Recurrent Low Back Pain
    Intervention:   Drug: Investigational medical product (IMP) administered in parent study
    Sponsors:   Pfizer;   Eli Lilly and Company
    Active, not recruiting
  • Robotic vs. Freehand Corrective Surgery for Pediatric Scoliosis
    NCT02084264
    Condition:   Scoliosis
    Intervention:  
    Sponsor:   Mazor Robotics
    Terminated
  • To Assess Safety, Tolerability and Physiological Effects on Structure and Function of AXA4010 in Subjects With Sickle Cell Disease
    NCT04134299
    Conditions:   To Assess the Safety and Tolerabiltiy of an Amino Acid Composition in Subjects With Sickle Cell Disease;   Anemia, Sickle Cell;   Sickle Cell Anemia;   Sickle Cell Disorders;   Sickle Cell Disease
    Intervention:   Dietary Supplement: AXA4010
    Sponsor:   Axcella Health, Inc
    Recruiting
  • Myopia Assessment of Two Manufacturing Processes
    NCT04126057
    Condition:   Juvenile Myopia
    Intervention:   Device: SightGlass Vision DOT Spectacle Lenses
    Sponsor:   SightGlass Vision, Inc.
    Recruiting
  • Expanded Indications in the MED-EL Pediatric Cochlear Implant Population
    NCT03900897
    Condition:   Hearing Loss, Sensorineural
    Intervention:   Device: MED-EL SYNCHRONY PIN Cochlear Implant
    Sponsor:   Med-El Corporation
    Recruiting
  • A Study of Lymphoseek® as a Lymphoid Tissue Targeting Agent in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node Mapping
    NCT02509598
    Conditions:   Rhabdomyosarcoma;   Melanoma
    Interventions:   Drug: Tc99m tilmanocept;   Drug: Vital Blue Dye (optional)
    Sponsor:   Cardinal Health 414, LLC
    Completed
  • Gastrointestinal Tract Microbiome in Healthy Term Infants Receiving Mother'S-own Breast Milk or Cow's Milk-based Infant Formulas
    NCT04059666
    Condition:   Gastrointestinal Microbiome
    Interventions:   Other: Investigational;   Other: Control
    Sponsor:   Mead Johnson Nutrition
    Recruiting
  • iKanEat: A Randomized-controlled, Multi-center Trial of Megestrol for Chronic Oral Food Refusal in Children
    NCT03815019
    Conditions:   Feeding Behavior;   Feeding Disorder of Infancy or Early Childhood
    Interventions:   Drug: Megestrol Acetate;   Behavioral: iKanEat Behavioral Intervention
    Sponsor:   University of Kansas Medical Center
    Recruiting
  • Oropharyngeal Administration of Mother's Colostrum for Premature Infants
    NCT02116699
    Conditions:   Infection;   Enterocolitis, Necrotizing;   Ventilator-associated Pneumonia
    Interventions:   Other: oropharyngeal mother's milk;   Other: oropharyngeal sterile water
    Sponsors:   NorthShore University HealthSystem;   The Gerber Foundation;   Fundacion Para La Investigacion Hospital La Fe;   University of Chicago
    Recruiting
  • Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALD
    NCT02357576
    Condition:   Cholestasis
    Intervention:   Drug: Intralipid 20% I.V. Fat Emulsion
    Sponsors:   University of Michigan;   Seattle Children's Hospital;   University of Florida;   Primary Children's Hospital;   University of Colorado, Denver
    Terminated
  • eHealth Evidence-based Intervention (EBI) for Latino Youth in Primary Care
    NCT03009539
    Conditions:   Sexual Risk Behavior;   Drug Use;   Family Functioning
    Intervention:   Behavioral: eHealth Familias Unidas Primary Care
    Sponsors:   University of Miami;   National Institute on Drug Abuse (NIDA)
    Active, not recruiting
  • A Study to Test if TEV-50717 is Effective in Relieving Tics Associated With Tourette Syndrome
    NCT03571256
    Condition:   Tourette Syndrome
    Interventions:   Drug: deutetrabenazine Low;   Drug: deutetrabenazine High;   Drug: Placebo
    Sponsors:   Teva Branded Pharmaceutical Products, R&D Inc.;   Nuvelution TS Pharma, Inc.
    Active, not recruiting
  • A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine
    NCT03432286
    Condition:   Episodic Migraine
    Interventions:   Drug: Galcanezumab;   Drug: Placebo
    Sponsor:   Eli Lilly and Company
    Recruiting
  • Evaluate the Safety of a Single Oral Dose of Solosec™ (Secnidazole) 2g for the Treatment of Adolescent Girls With BV
    NCT03937869
    Condition:   Bacterial Vaginoses
    Intervention:   Drug: Secnidazole
    Sponsor:   Lupin Research Inc
    Recruiting
  • Investigation of Cognitive Outcomes With Cannabidiol Oral Solution
    NCT04133480
    Condition:   Lennox-Gastaut Syndrome
    Intervention:   Drug: GWP42003-P
    Sponsor:   GW Research Ltd
    Not yet recruiting
  • Effects of a Orally Inhaled Fluticasone Furoate on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma Over a Year
    NCT02889809
    Condition:   Asthma
    Interventions:   Drug: Fluticasone furoate;   Drug: Placebo;   Drug: Montelukast;   Drug: Short Acting Beta 2 Agonist
    Sponsor:   GlaxoSmithKline
    Recruiting
  • IBP-9414 for the Prevention of Necrotizing Enterocolitis - The Connection Study
    NCT03978000
    Condition:   Necrotizing Enterocolitis
    Interventions:   Drug: IBP-9414;   Drug: Placebo
    Sponsor:   Infant Bacterial Therapeutics
    Recruiting
  • KP415 Open-Label Safety Study in Children (6-12 Years of Age) With ADHD
    NCT03460652
    Condition:   ADHD
    Intervention:   Drug: KP415 oral capsule
    Sponsor:   KemPharm, Inc.
    Completed
  • Growth and Tolerance of Young Infants Fed Infant Formula
    NCT04105686
    Condition:   Growth and Tolerance
    Interventions:   Other: Control Infant Formula;   Other: Experimental Infant Formula
    Sponsor:   Abbott Nutrition
    Recruiting
  • Patient Perception of Treatment Burden in Weekly Versus Daily Growth Hormone Injections in Children With GHD
    NCT03831880
    Condition:   Growth Hormone Deficiency
    Interventions:   Drug: Genotropin;   Drug: somatrogon
    Sponsor:   Pfizer
    Recruiting
  • A Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety Disorder
    NCT03924323
    Conditions:   Anxiety Disorders;   Generalized Anxiety Disorder
    Interventions:   Drug: Escitalopram;   Other: Placebo
    Sponsor:   Allergan
    Recruiting
  • Treatment of Impulsive Aggression (IA) in Adolescent With ADHD in Conjunction With Standard ADHD Treatment
    NCT03597503
    Condition:   Attention Deficit Hyperactivity Disorder
    Interventions:   Drug: SPN-810;   Drug: Placebo
    Sponsor:   Supernus Pharmaceuticals, Inc.
    Recruiting
  • JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis
    NCT03796676
    Condition:   Atopic Dermatitis
    Interventions:   Drug: Placebo;   Drug: PF-04965842;   Drug: PF04965842
    Sponsor:   Pfizer
    Recruiting
  • Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US
    NCT03537508
    Condition:   Meningococcal Infections
    Interventions:   Biological: MenACYW conjugate vaccine;   Biological: MenACYW-135 conjugate vaccine;   Biological: DTaP-IPV//Hib vaccine;   Biological: Pneumococcal 13-valent conjugate vaccine;   Biological: Pentavalent rotavirus vaccine;   Biological: Hepatitis B vaccine;   Biological: Measles, mumps, rubella (MMR) vaccine;   Biological: Varicella vaccine;   Biological: Hepatitis A vaccine
    Sponsor:   Sanofi Pasteur, a Sanofi Company
    Recruiting
  • Safety and Efficacy of NBI-98854 in Pediatric Subjects With Tourette Syndrome
    NCT03530293
    Condition:   Tourette Syndrome
    Interventions:   Drug: Valbenazine;   Drug: Placebo oral capsule
    Sponsor:   Neurocrine Biosciences
    Terminated
  • Efficacy and Safety of SHP465 at 6.25 mg in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-12 Years
    NCT03325881
    Condition:   Attention Deficit Hyperactivity Disorder (ADHD)
    Interventions:   Drug: SHP465;   Drug: Placebo
    Sponsor:   Shire
    Completed
  • Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers
    NCT03673462
    Condition:   Healthy Volunteers (Meningococcal Infection)
    Interventions:   Biological: Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid conjugate vaccine (MenACYW conjugate vaccine);   Biological: Meningococcal (Groups A, C, Y and W 135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine (MENVEO®);   Biological: Diphtheria, Tetanus, Acellular Pertussis, Poliovirus and Haemophilus b Vaccine;   Biological: Pneumococcal 13-valent Conjugate Vaccine;   Biological: Rotavirus Vaccine;   Biological: Hepatitis B Vaccine;   Biological: Measles, Mumps, and Rubella Virus Vaccine;   Biological: Varicella Virus Vaccine
    Sponsor:   Sanofi Pasteur, a Sanofi Company
    Recruiting
  • Safety and Efficacy Study of Fluticasone Furoate/Vilanterol (FF/VI) Fixed Dose Combination (FDC) Compared to FF Alone in Subjects With Asthma
    NCT03248128
    Condition:   Asthma
    Interventions:   Drug: FF/VI via ELLIPTA DPI;   Drug: FF via ELLIPTA DPI
    Sponsor:   GlaxoSmithKline
    Recruiting
  • A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in Healthy Late Preterm and Term Infants
    NCT03979313
    Condition:   Respiratory Syncytial Virus Infections
    Interventions:   Drug: MEDI8897;   Drug: Placebo
    Sponsor:   MedImmune LLC
    Recruiting
  • Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM
    NCT03429543
    Condition:   Diabetes Mellitus, Type 2
    Interventions:   Drug: Linagliptin;   Drug: Empagliflozin;   Drug: Placebo
    Sponsor:   Boehringer Ingelheim
    Recruiting
  • Efficacy, Safety, and Tolerability of Levomilnacipran ER in Pediatric (7-17 Years) With Major Depressive Disorder
    NCT03569475
    Condition:   Major Depressive Disorder
    Interventions:   Drug: Levomilnacipran ER;   Drug: Fluoxetine;   Drug: Placebo
    Sponsor:   Allergan
    Recruiting
  • Efficacy & Safety Of Zomig Nasal Spray For Acute Migraine Treatment In Subjects 6 To 11 Years, With OLE
    NCT03275922
    Condition:   Migraine
    Interventions:   Drug: Placebo ZNS;   Drug: ZNS
    Sponsors:   Impax Laboratories, LLC;   AstraZeneca
    Recruiting
  • Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder
    NCT03768726
    Condition:   Bipolar Disorder
    Intervention:   Drug: Ziprasidone
    Sponsor:   Pfizer
    Recruiting
  • Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers
    NCT03691610
    Condition:   Healthy Volunteers (Meningococcal Infection)
    Interventions:   Biological: Meningococcal Polysaccharide (Serogroups A,C,Y and W) Tetanus Toxoid Conjugate vaccine MenACYW conjugate vaccine;   Biological: Meningococcal (Groups A, C, Y and W 135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine;   Biological: Meningococcal Polysaccharide (serogroups A,C,Y and W-135) Diphtheria Toxoid Conjugate Vaccine;   Biological: Diphtheria and Tetanus Toxoids and Acellular Pertussis, inactivated Poliovirus and Haemophilus b Conjugate Vaccine;   Biological: Diphtheria and Tetanus Toxoids and Acellular Pertussis, Hepatitis B and Inactivated Poliovirus Vaccine;   Biological: Haemophilus b Conjugate Vaccine;   Biological: Pneumococcal 13-valent Conjugate Vaccine;   Biological: Rotavirus Vaccine, Live, Oral, Pentavalent;   Biological: Hepatitis B Vaccine;   Biological: Measles, Mumps, and Rubella Virus Vaccine Live;   Biological: Varicella Virus Vaccine Live
    Sponsor:   Sanofi Pasteur, a Sanofi Company
    Recruiting

Popular Now

  • Privacy Policy
  • Ad and Cookie Policy
  • Infringement Policy
  • Terms of Use
  • Email Policy
  • Contact Us
  • Post Clinical Trials
  • Join Clinical Trials
  • Volunteer Login
  • Recruiters Login
  • Frequently Asked Questions
  • Blog
  • Find Clinical Trials
  • Find Volunteers
  • Trials by Category
  • Trials by Location
  • Volunteers by Category
  • Volunteers by Location
All clinical trials are registered and certified with clinicaltrials.gov. Data via U.S. National Library of Medicine,U.S. National Institutes of Health, U.S. Department of Health & Human Services. JoinClinicaltrials.com (Aunica Media llc) is a free resource that provides individuals and companies with information regarding clinical trials that are being conducted nationwide. Aunica Media llc does not conduct clinical trials nor endorses them. Please consult your doctor or physician before participating. And Ye shall know the truth, and the truth shall make you free
©2001-2019 Aunica Media LLC